Skip to main content
SpringerLink
Log in

Models of Palliative Care Service Delivery

What is Most Cost Effective?

  • Review Article
  • Published:
Disease Management & Health Outcomes

Abstract

Palliative care has been through a difficult development process, but now has the evidence and experience base to make a contribution in the changing health environment. There has now been a great deal of experience with different types of care, and research has shown that patients strongly prefer home-based care. Research on outcomes has inevitably proved difficult, but the evidence on patient perspectives is strong. The aim of ensuring privacy, dignity and control in the last phase of life is a very positive one and is attainable for most patients. Health funders should be keen to drive forward advances in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bosanquet N, Salisbury C, editors. Providing a palliative care service. Oxford: Oxford University Press, 1999.

    Google Scholar 

  2. Greer DS, Mor V, Morris JN, et al. An alternative in terminal care: results of the National Hospice Study. J Chron Dis 1986; 39: 9–26.

    Article  PubMed  CAS  Google Scholar 

  3. Zimmer JG, Groth Juncker A, McCusker J. A randomized controlled study of a home health care team. Am J Public Health 1985; 75: 134–41.

    Article  PubMed  CAS  Google Scholar 

  4. Hughes SL, Cummings J, Weaver F, et al. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill. Health Serv Res 1992; 26: 801–17.

    PubMed  CAS  Google Scholar 

  5. Emanuel EJ. Cost savings at the end of life: what do the data show? JAMA 1996; 275: 1907–14.

    Article  PubMed  CAS  Google Scholar 

  6. Devine EC, Westlake SK. The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies. Oncol Nurs Forum 1995; 22: 1369–81.

    PubMed  CAS  Google Scholar 

  7. Pawling Kaplan M, O’Connor P. Hospice care for minorities: an analysis of a hospital-based inner city palliative care service. Am J Hosp Care 1989; 6: 13–21.

    Article  PubMed  CAS  Google Scholar 

  8. Parkes CM. Terminal care evaluation of in-patient service at St. Christopher’s Hospice: part 1 and 2. Postgrad Med J 1979; 55: 517–25.

    Article  PubMed  CAS  Google Scholar 

  9. Parkes CM. Terminal care: evaluation of an advisory domiciliary service at St. Christopher’s Hospice. Postgrad Med J 1980; 56: 685–9.

    Article  PubMed  CAS  Google Scholar 

  10. Hinton J. Comparison of places and policies for terminal care. Lancet 1979; 1: 29–32.

    Article  PubMed  CAS  Google Scholar 

  11. Eilershaw JE, Peat SJ, Boys LC. Assessing the effectiveness of a hospital palliative care time. Palliative Med 1995; 9: 145–52.

    Article  Google Scholar 

  12. Raftery JP, Addington-Hall JM, MacDonald LD, et al. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients. Palliative Med 1996; 10: 151–61.

    Article  CAS  Google Scholar 

  13. Ingleton C, Faulkner A. Quality assurance in palliative care: some of the problems. Eur J Cancer Care 1995; 4: 38–44.

    Article  CAS  Google Scholar 

  14. Ingleton C, Faulkner A. Quality assurance in palliative care -a review of the literature. J Cancer Care 1995; 4: 49–55.

    Google Scholar 

  15. Tierney AJ, Sladden S, Anderson J, et al. Measuring the costs and quality of palliative care: a discussion paper. Palliative Med 1994; 8: 273–81.

    Article  CAS  Google Scholar 

  16. Hill F, Oliver C. Hospice -an update on the cost of patient care. Health Trends 1988; 20: 83–7.

    PubMed  CAS  Google Scholar 

  17. Gray D, MacAdam D, Boldy D. A comparative cost analysis of terminal cancer care in home hospital patients and controls. J Chron Dis 1987; 40: 801–10.

    Article  PubMed  CAS  Google Scholar 

  18. Glare PA, Lickiss JN. Quality assurance in palliative care. Med J Aust 1992; 157: 572.

    PubMed  CAS  Google Scholar 

  19. Ventafridda V, De Conno F, Ripamonti C, et al. Comparison of home and hospital care of advanced cancer patients. Tumori 1989; 75: 619–25.

    PubMed  CAS  Google Scholar 

  20. Mercandante S, Genovese G, Kargar JA, et al. Home palliative care: results in 1991 versus 1988. J Pain Symptom Manage 1992; 7: 414–8.

    Article  Google Scholar 

  21. Pannuti F, Tanneberger S. The Bologna Eubiosia Project: hospital-at-home care for advanced cancer patients. J Palliat Care 1992; 8: 11–7.

    PubMed  CAS  Google Scholar 

  22. Wilkinson EK, Salisbury C, Bosanquet N. Patient and carer preference for, and satisfaction with, specialist models of palliative care: a systematic literature review. Palliative Med 1999; 13: 197–216.

    Article  CAS  Google Scholar 

  23. Townsend J, Frank AO, Fermont D. Terminal cancer care and patients’ preference for place of death: a prospective study. BMJ 1990; 301: 415–7.

    Article  PubMed  CAS  Google Scholar 

  24. McCann K. The work of a specialist AIDS home support team: the views and experiences of patients using the service. J Adv Nurs 1991; 16: 832–6.

    Article  PubMed  CAS  Google Scholar 

  25. Guest JF, Hart WM, Cookson RF. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Pharmacoeconomics 1998; 3: 285–97.

    Article  Google Scholar 

  26. Porzsolt F, Zeeh J, Platt D. Palliative therapies in elderly cancer patients. Drugs Aging 1995; 3: 192–209.

    Article  Google Scholar 

  27. Ragnarson-Tennvall G, Wilking N. Treatment of locally advanced pancreatic carcinoma in Sweden. Pharmacoeconomics 1999; 4: 377–84.

    Article  Google Scholar 

  28. Peuckmann V, Fisch M, Bruera E. Potential novel uses of thalidomide. Focus on palliative care. Drugs 2000; 2: 273–92.

    Article  Google Scholar 

  29. O’siorain L. The role of transdermal fentanyl in palliative care. Clin Drug Invest 1998; 1: 71–2.

    Google Scholar 

Download references

Acknowledgements

There were no sources of funding or conflicts of interest for this article.

Author information

Authors and Affiliations

  1. Department of Bioengineering, Imperial College, University of London, Bagrit Centre, Exhibition Road, London, S.W7 2BX, UK

    Nick Bosanquet (director)

Authors
  1. Nick Bosanquet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nick Bosanquet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bosanquet, N. Models of Palliative Care Service Delivery. Dis-Manage-Health-Outcomes 10, 349–353 (2002). https://doi.org/10.2165/00115677-200210060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200210060-00004

Keywords

Search

Navigation